You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Patent: 10,385,131


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,385,131
Title:Combination therapies of HDAC inhibitors and PD-L1 inhibitors
Abstract: Provided herein are combinations that include an HDACi and a PD-L1 inhibitor that are useful for treating cancer, including cancer resistant to PD-1 inhibitors.
Inventor(s): Bissonnette; Reid P. (Carlsbad, CA), Rolland; Alain (San Diego, CA), Gillings; Mireille (Winchester CDP, NV)
Assignee: HUYA Bioscience International, LLC (San Diego, CA)
Application Number:15/592,929
Patent Claims:see list of patent claims

Details for Patent 10,385,131

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. TECENTRIQ atezolizumab Injection 761034 05/18/2016 ⤷  Try a Trial 2036-05-11
Genentech, Inc. TECENTRIQ atezolizumab Injection 761034 03/08/2019 ⤷  Try a Trial 2036-05-11
Emd Serono, Inc. BAVENCIO avelumab Injection 761049 03/23/2017 ⤷  Try a Trial 2036-05-11
Astrazeneca Uk Ltd IMFINZI durvalumab Injection 761069 05/01/2017 ⤷  Try a Trial 2036-05-11
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.